Clinical trials: Frequency of Treatment Protocol
- Condition Frequency of Treatment Protocol
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Healthy Volunteers
A Study to Investigate the Impact of Dose and Dosing Frequency of AZD8848 on the Response on Biomarkers
The study will investigate how the dose of AZD8848 and the dosing frequency will affect the immunological/inflammatory response by measuring the production of biomarkers in blood and nasal lavage.
- Trial name
- NCT01203124
- Testing
- AZD8848
- Where
- Sweden
- Volunteers
- 55 people, healthy volunteers welcome
- Sponsor
- AstraZeneca